MedTrace Logo

Magnesium as Adjuvant for Sciatic Block

NCT02198547 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-08-26

No results posted yet for this study

Summary

The aim of the study is to evaluate if Magnesium added to ropivacaine can reduce onset time and can enhance offset time.

Conditions

  • Hallux Valgus

Interventions

DRUG

Magnesium Sulfate

Mg used with ropivacaine for sciatic nerve blick

DRUG

Ropivacaine

Ropivacaine 7,5 mg/ml used for sciatic nerve block

Sponsors & Collaborators

  • Campus Bio-Medico University

    lead OTHER

Principal Investigators

  • Massimiliano Carassiti, MD · Campus Bio Medico

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2020-07-01
Completion
2022-09-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02198547 on ClinicalTrials.gov